Evidence map›Paper›PMID 42548916›Full record

ArticleClinical case reports2026

A Challenging Case of Advanced Cardiac Sarcoidosis Refractory to Infliximab Therapy.

Manal Ibrahim, Mansimran Singh Dulay, Kshama Wechalekar, Vasileios Kouranos, Rakesh Sharma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manal IbrahimDepartment of Cardiology Royal Brompton Hospital, Part of Guy's and St Thomas's NHS Foundation Trust London UK.ORCID https://orcid.org/0000-0001-9825-4102
Mansimran Singh DulayDepartment of Cardiology Royal Brompton Hospital, Part of Guy's and St Thomas's NHS Foundation Trust London UK.ORCID https://orcid.org/0009-0002-2319-8876
Kshama WechalekarNational Heart and Lung Institute Imperial College London London UK.ORCID https://orcid.org/0000-0001-6852-5370
Vasileios KouranosDepartment of Cardiology Royal Brompton Hospital, Part of Guy's and St Thomas's NHS Foundation Trust London UK.ORCID https://orcid.org/0000-0002-2723-0928
Rakesh SharmaDepartment of Cardiology Royal Brompton Hospital, Part of Guy's and St Thomas's NHS Foundation Trust London UK.ORCID https://orcid.org/0000-0002-9418-2655

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac sarcoidosis can be life-threatening, and lack of response to immunosuppressive therapy remains a significant challenge in active disease. We present a case of refractory cardiac sarcoidosis despite third-line immunosuppression (infliximab). Ongoing multimodality assessment is essential for managing refractory cardiac sarcoidosis.

Indexed as

cardiac magnetic resonance imaging immunosuppressantfluorodeoxyglucose positron emission tomographyguideline directed medical therapyinfliximablate gadolinium enhancementsustained ventricular arrythmia

Identifiers

PMID42548916
PMCPMC13429930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.